• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.63% Nasdaq Down0.99%

    TrovaGene, Inc. (TROV)

    9.77 Down 0.33(3.26%) 10:15AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    ProfileGet Profile for:
    TrovaGene, Inc.
    11055 Flintkote Avenue
    Suite B
    San Diego, CA 92121
    United States - Map
    Phone: 858-952-7570
    Website: http://www.trovagene.com

    Index Membership:N/A
    Full Time Employees:31

    Business Summary 

    Trovagene, Inc., a molecular diagnostic company, focuses on the development and commercialization of proprietary urine-based cell-free molecular diagnostic technology for use in disease detection and monitoring across various medical disciplines. The company intends to enhance the treatment outcomes for cancer patients through its proprietary technology to detect and quantitatively monitor cell-free DNA using urine or blood samples. It is developing PCM BRAF and KRAS mutation detection tests for detecting mutations in metastatic cancer patients; and HPV HR detection test to detect the presence of various HPV genotypes using a urine sample. The company was formerly known as Xenomics, Inc. and changed its name to Trovagene, Inc. in January 2010. Trovagene, Inc. was founded in 1999 and is headquartered in San Diego, California.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on TrovaGene, Inc.

    Key Executives 
    Dr. Antonius P. Schuh Ph.D., 51
    Chief Exec. Officer and Director
    Mr. Stephen L. Zaniboni MBA, CPA, 57
    Chief Financial Officer
    Dr. Mark Erlander Ph.D.,
    Chief Scientific Officer
    Mr. David S. Moskowitz R.Ph.,MBA,
    VP of Investor Relations
    Mr. B. Keith McCormick MBA,
    VP of Sales & Sales Operations
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders